Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021

Rhea-AI Summary

Meridian Bioscience, Inc. (NASDAQ: VIVO) will report its first quarter fiscal 2021 financial results on February 5, 2021. CEO Jack Kenny and CFO Bryan Baldasare will host a conference call at 10:00 a.m. ET to discuss the results. Interested participants in the U.S. can call (866) 443-5802, while international callers can dial (513) 360-6924. A replay of the call will be available for 14 days starting at 1:00 p.m. ET on the same day. Meridian is a leading provider of diagnostic testing solutions and life science raw materials, operating in over 70 countries.

Positive

• Meridian is set to provide Q1 fiscal 2021 financial results, indicating ongoing business activity.
• The scheduled conference call allows investors and stakeholders to gain insights directly from leadership.

Negative

• None.

CINCINNATI, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter fiscal 2021 financial results Friday, February 5, 2021.

Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.

To participate in the live call by telephone from the U.S., dial (866) 443-5802, or from outside the U.S., dial (513) 360-6924, and enter the audience pass code 5617405.

A replay will be available for 14 days beginning at 1:00 p.m. Eastern Time on February 5, 2021 by dialing (855) 859-2056 or (404) 537-3406 and entering pass code 5617405.

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

FAQ

When will Meridian Bioscience report its Q1 fiscal 2021 financial results?

Meridian Bioscience will report its Q1 fiscal 2021 financial results on February 5, 2021.

What time is the conference call for Meridian's financial results?

The conference call for Meridian's financial results will be held at 10:00 a.m. Eastern Time on February 5, 2021.

How can I participate in Meridian Bioscience's conference call?

To participate in the conference call, U.S. callers can dial (866) 443-5802 and international callers can dial (513) 360-6924.

Is there a replay available for the conference call?

Yes, a replay of the conference call will be available for 14 days starting at 1:00 p.m. Eastern Time on February 5, 2021.